Wall Street Just Upgraded Oracle, Despite Earnings Disappointment

Photo of Ian Cooper
By Ian Cooper Published

Quick Read

  • Today, markets are in the red after Oracle posted revenue of $16.06 billion, which is less than the $16.21 billion analysts were expecting.

  • UBS analysts just reiterated a buy rating on Micron with a price target of $295 ahead of earnings next week.

  • And down, but not out, shares of Netflix are being viewed positively by analysts at Needham.
  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Micron Technology didn't make the cut. Grab the names FREE today.

Wall Street Just Upgraded Oracle, Despite Earnings Disappointment

© 24/7 Wall St.

Just yesterday, markets celebrated the latest quarter-point cut from the Federal Reserve, which lowered rates to a range of 3.5% to 3.75%.

The central bank also announced that it would again purchase short-term bonds, thereby driving down short-term yields. It also removed language that the labor market “remained low.” That could mean the central bank may be more likely to ease to support the jobs market and not care as much about sticky inflation. At the same time, we may only see one cut next year.

Markets exploded on the news.

Today, markets are in the red after Oracle (NYSE: ORCL | ORCL Price Prediction) posted revenue of $16.06 billion, which is less than the $16.21 billion analysts were expecting. Software revenue was. $5.88 billion, which missed estimates for $6.06 billion.

However, despite the news, analysts are still bullish.

Wells Fargo, for example, has an overweight rating with a $280 price target. Bank of America has a buy rating and a price target of $300. Barclays has an overweight rating with a price target of $310 a share. UBS has a buy rating with a $325 price target.

Micron 

UBS analysts just reiterated a buy rating on Micron (NASDAQ: MU) with a price target of $295 ahead of earnings next week. As quoted by CNBC, “Against this backdrop of tightening supply, we walk EPS estimates higher yet again and see EPS of ~$38 out in C2027E, justifying a PT of $295 (up from $275), and we remain Buy rated.”

Just yesterday, analysts at HSBC initiated coverage of MU with a buy rating and a $330 price target. Analysts at BNP Paribas also say Micron is likely to benefit from a “historic upcycle” aided by artificial intelligence.

Netflix 

And down, but not out, shares of Netflix (NASDAQ: NFLX) are being viewed positively by analysts at Needham. The firm has a buy rating on NFLX and doesn’t believe it needs Warner Bros. Discovery. According to the firm, “NFLX buying WBD would put $83B of additional value at risk of being disrupted by GenAI. Without WBD, NFLX is more global, more nimble, more tech-first, and has more flexibility with the Hollywood unions (called Guilds),” as quoted by CNBC.

Just the other day, Evercore ISI reiterated an outperform rating on NFLX.  The firm noted, “We acknowledge that NFLX shares have been largely reactive to recent developments re: potential strategic outcomes. But we believe Netflix’s long-term fundamental outlook is increasingly strengthening, thanks to its highly compelling value proposition, its excellent execution track record, and its improved global, competitive positioning,” as quoted by CNBC.

Photo of Ian Cooper
About the Author Ian Cooper →

Ian Cooper is a veteran market analyst and investment strategist with more than 20 years of experience covering stocks, commodities, and macro trends. Since 1999, he has helped investors identify market opportunities using a blend of technical analysis, fundamental research, and market sentiment.

He is the creator of the ADD News Flow Strategy, which focuses on trading market reactions to major news events and investor psychology. Cooper was also among the analysts who warned about the 2008 financial crisis and major financial institution collapses ahead of the broader market.

Before joining 247 Wall St., Cooper wrote extensively for InvestorPlace and other financial publications, covering market trends, trading strategies, and investment opportunities.

Continue Reading

Top Gaining Stocks

TPL Vol: 485,229
MRNA Vol: 6,929,589
INCY Vol: 2,269,213
URI Vol: 860,132
MDT Vol: 20,284,124

Top Losing Stocks

CTRA Vol: 73,319,495
GPN Vol: 11,471,568
CHTR Vol: 4,395,420
NOW Vol: 34,312,777
IBM
IBM Vol: 13,892,615